Simple Mobile technology health management tool for people with severe mental illness: a randomised controlled feasibility trial

Table 3 Clinical outcome measures (ANCOVAs, adjusted for baseline score)

	‘Florence & TAU’			TAU			Difference (95% CI)
	N	Mean	s.d.	N	Mean	s.d.
DIALOG PROM mean score 8 items
- at baseline	30	4.6	0.8	24	4.3	1.4
- post-treatment	30	4.8	1.1	24	4.6	1.2	−0.27 (−0.51 to −0.02) *
DIALOG PREM mean score 3 items
- at baseline	31	5.6	0.9	25	5.1	1.4
- post-treatment	31	5.7	1.0	25	5.3	1.0	−0.14 (−0.49 to 0.20) n.s.
General Self Efficacy Scale (GSE)
- at baseline	30	2.8	0.7	23	2.7	0.8
- post-treatment	30	2.7	0.7	23	2.8	0.6	0.16 (−0.17 to 0.20) n.s.
Mental Health Confidence Scale
- at baseline	29	65.4	15.4	24	61.8	19.5
- post treatment	29	62.4	17.2	24	66.5	15.5	−0.85 (−4.97 to 3.23) n.s.
Medication Adherence Scale (MARS)
- at baseline	31	7.7	2.1	25	7.6	2.7
- post-treatment	31	7.6	2.3	25	7.7	2.1	−0.14 (−0.79 to 0.50) n.s.

DIALOG PROM: Patient Reported Outcome Measures, mean across 8 domains (mental health, physical health, job situation, accommodation, leisure activities, relationships, friendships, personal safety); DIALOG PREM: Patient Reported Experience Measures, mean across 3 domains (satisfaction with: medication, practical help, meetings); n.s not significant; TAU Treatment as usual; * The mean difference is significant at the .05 level.
*Each Scale is positively ranked where higher scores indicate higher satisfaction/efficacy/confidence/adherence

ISSN: 1471-244X